Mizuho downgrades Tronox stock to Underperform on unwarranted price surge

Mizuho downgraded Tronox (TROX) to Underperform with a $4 price target, citing an "unwarranted" 55% stock price increase since its last quarterly report and dividend cut, alongside deteriorating fundamentals. The firm highlighted disappointing Q2 2025 EPS of -$0.28 against an expected -$0.04, elevated net debt-to-EBITDA at 7x, and anticipated lower titanium dioxide prices in H2 2025, suggesting the stock could retest previous lows due to these underlying weaknesses.

Analysis

Mizuho's downgrade of Tronox (TROX) to Underperform with a $4.00 price target highlights a significant disconnect between the stock's recent performance and its underlying fundamentals. The firm flags an "unwarranted" 55% stock price increase since the last dividend cut, which sharply contrasts with the S&P Materials index's 5% gain over the same period. This valuation concern is substantiated by a severe Q2 2025 earnings miss, where EPS came in at -$0.28 against a -$0.04 consensus estimate—a 600% negative surprise—and revenue fell short at $731 million versus a $790.22 million forecast. Looking forward, the outlook for titanium dioxide, Tronox's primary product, appears weak, as major paint manufacturers anticipate lower raw material prices in the second half of 2025. Compounding these issues is the company's precarious financial health, evidenced by an elevated net debt-to-EBITDA ratio of approximately 7x for the next twelve months, far exceeding its target of 2x. The resignation of a board and Audit Committee member, while attributed to external time commitments, adds another layer of change amidst these operational and financial challenges.

Key Decisions for Investors

• Investors should view the recent 55% stock rally with extreme caution, as it appears disconnected from the company's severe Q2 2025 earnings miss and recent dividend cut.
• It is critical to monitor titanium dioxide pricing trends, as negative guidance from key customers points to lower prices in H2 2025, which could further compress Tronox's margins and revenue.
• The company's high leverage, with a net debt-to-EBITDA ratio near 7x, poses a significant financial risk, making any long position vulnerable to the potential stock re-test of previous lows suggested by the analyst downgrade.